When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes

American Journal of Cardiovascular Drugs · Published 2026-07-23 · DOI 10.1007/s40256-026-00817-5

Authors (14)

Zeyad Elariny, Omar Salem, Mohamad Ashraf Salaheldin, Adham Ahmed, Farida Rabie, Maryam Mohamed Sayed, Mohamed Harish, Mohamed Ali, Selim Ahmed Eliwa, Mohammad Elshorbagy, Sara ElHarouni, Ahmed Abdelmeguid, Retaj Ahmed, Omnia Azmy Nabeh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Elariny, Z., Salem, O., Salaheldin, M., et al. (2026). When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00817-5

Related articles

• GRADE: an emerging consensus on rating quality of evidence and strength of recommendations · BMJ · 2008 · Cites or is cited by this article
• Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly · American Journal of Cardiovascular Drugs · 2025 · Same journal
• Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion · American Journal of Cardiovascular Drugs · 2025 · Same journal
• Contemporary Oral Medication Use and Frequency in Patients with Transthyretin Amyloid Cardiomyopathy · American Journal of Cardiovascular Drugs · 2025 · Same journal
• Cardiovascular Outcomes Associated with Cholinesterase Inhibitor Use in Individuals at High Cardiovascular Risk · American Journal of Cardiovascular Drugs · 2025 · Same journal
• Redefining Cardiac Sarcoidosis with Advanced Imaging and Therapeutic Strategies · American Journal of Cardiovascular Drugs · 2025 · Same journal
• One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE Registry · American Journal of Cardiovascular Drugs · 2025 · Same journal
• De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making · American Journal of Cardiovascular Drugs · 2026 · Same journal
• Cost-Effectiveness and Price Threshold Analysis of Tafolecimab in Chinese Patients with Elevated LDL Cholesterol Despite Statin Therapy · American Journal of Cardiovascular Drugs · 2025 · Same journal
• Comparative Effectiveness of Sacubitril/Valsartan Versus Sodium-Glucose Cotransporter 2 Inhibitors among Patients with Heart Failure with Reduced Ejection Fraction with or without Diabetes: A Cohort Study · American Journal of Cardiovascular Drugs · 2026 · Same journal